Medicine
Duaklir Pressair 400 mcg/12 mcg inhalation powder
Duaklir Pressair 400 mcg/12 mcg inhalation powder is a prescription medicine containing Aclidinium and Formoterol for inhalation use, marketed by Covis Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store DUAKLIR PRESSAIR in a dry place at 20°C-25°C (68°F-77°F), excursions…
Key facts
- Active ingredient (INN)
- Aclidinium and Formoterol
- Brand
- Duaklir Pressair
- Strength
- 400 mcg/12 mcg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 1 pouch
- Marketing authorisation holder
- Covis Pharma
- Manufacturer
- Covis Pharma
- Origin register
- US FDA, United States
- Storage
- Store DUAKLIR PRESSAIR in a dry place at 20°C-25°C (68°F-77°F), excursions permitted to 15-30°C (59-86°F). Do not store the inhaler on a vibrating surface. The PRESSAIR inhaler should be stored inside the sealed bag and only be opened immediately before use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03AL05 Aclidinium and Formoterol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 March 2019
- Identifiers
- RxCUI 2205094, 2205099, 2205103 +1DailyMed set ID 2eba3089-28b4-4190-9fba-2511246cfd16NDC 70515-001Application NDA210595
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 1 inhaler in 1 pouch / 60 powder, metered in 1 inhaler | 70515-001-01 | Covis Pharma | 29 March 2019 |
| 1 pouch in 1 carton / 1 inhaler in 1 pouch / 30 powder, metered in 1 inhaler | 70515-001-03 | Covis Pharma | 29 March 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Aclidinium and Formoterol is a fixed-dose combination of an anticholinergic and a beta2-adrenergic agonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), among other approved uses. MedsAcross supplies Aclidinium and Formoterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Aclidinium and FormoterolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DUAKLIR PRESSAIR prescribing information (Covis Pharma) · U.S. National Library of Medicine, DailyMed
- Brimica Genuair: European public assessment report (EPAR) · European Medicines Agency
- Duaklir Genuair: European public assessment report (EPAR) · European Medicines Agency
Need Duaklir Pressair 400 mcg/12 mcg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.